Literature DB >> 26292668

S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma.

Zhe Lin1, Lei Deng2, Jie Ji2, Ci Cheng1, Xin Wan1, Runqiu Jiang2, Junwei Tang2, Han Zhuo2, Beicheng Sun3, Yun Chen1.   

Abstract

To identify cellular target genes involved in NPC cell invasion and metastasis, gene expression profiles of CNE-1 cells with or without ectopic LMP2A expression were compared by using the metastatic gene array. S100 calcium binding protein A4 (S100A4) was the highest increased one among these genes both in mRNA and protein levels of NPC cells. Moreover, S100A4 was upregulated in LMP2A-positive NPC tissues. We found that CNE-1-S100A4 showed significantly increased invasion ability as compared to the controls both in vitro and in vivo, which indicated that S100A4 induced EMT occurrence and promoted metastasis. Notably, the DNA hypomethylation of S100A4 was found in LMP2A-positive NPC tissues. Besides, inhibition of DNA methyltransferases via 5-Aza-dC stimulated the expression of S100A4 in the cells without ectopic LMP2A expression. The methylation changes were confirmed by methylation specific PCR (MSP), suggesting that LMP2A ectopic expression led to the demethylation of S100A4 promoter. These results demonstrated that LMP2A-induced hypomethylation participated in regulating S100A4 expression in NPC. Our findings provide an evidence for the emerging notion that hypomethylation and activation of correlated genes are crucial for metastasis progression in cancer.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMT; LMP2A; NPC; S100A4; hypomethylation

Mesh:

Substances:

Year:  2015        PMID: 26292668     DOI: 10.1002/mc.22389

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

Review 1.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

Review 2.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

3.  Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.

Authors:  Yung-Che Chen; Meng-Chih Lin; Chang-Chun Hsiao; Yi-Xin Zheng; Kuang-Den Chen; Ming-Tse Sung; Chung-Jen Chen; Ting-Ya Wang; Yong-Yong Lin; Huang-Chih Chang; Yu-Mu Chen; Jen-Chieh Chang
Journal:  Oncotarget       Date:  2017-07-11

4.  Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.

Authors:  Giridhar Mudduluru; Katharina Ilm; Steffen Fuchs; Ulrike Stein
Journal:  Oncotarget       Date:  2017-03-28

5.  Annexin A1 can inhibit the in vitro invasive ability of nasopharyngeal carcinoma cells possibly through Annexin A1/S100A9/Vimentin interaction.

Authors:  Ying Xiao; Chenjie Ouyang; Weiguo Huang; Yunlian Tang; Weiting Fu; Ailan Cheng
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 6.  The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases.

Authors:  Linlin Zhang; Ran Wang; Zhengde Xie
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-28       Impact factor: 5.560

Review 7.  Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.

Authors:  Jie Yuan; Fei Zhang; Ruifang Niu
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.